Literature DB >> 20124479

Cell surface tetraspanin Tspan8 contributes to molecular pathways of exosome-induced endothelial cell activation.

Irina Nazarenko1, Sanyukta Rana, Alexandra Baumann, Jessica McAlear, Andrea Hellwig, Michael Trendelenburg, Günter Lochnit, Klaus T Preissner, Margot Zöller.   

Abstract

Tumor-derived exosomes containing the tetraspanin Tspan8 can efficiently induce angiogenesis in tumors and tumor-free tissues. However, little information exists on exosome-endothelial cell (EC) interactions or the proangiogenic role of tetraspanins, which are a constitutive component of exosomes. In this study, we used a rat adenocarcinoma model (AS-Tspan8) to explore the effects of exosomal Tspan8 on angiogenesis. Tspan8 contributed to a selective recruitment of proteins and mRNA into exosomes, including CD106 and CD49d, which were implicated in exosome-EC binding and EC internalization. We found that EC internalized Tspan8-CD49d complex-containing exosomes. Exosome uptake induced vascular endothelial growth factor (VEGF)-independent regulation of several angiogenesis-related genes, including von Willebrand factor, Tspan8, chemokines CXCL5 and MIF, chemokine receptor CCR1, and, together with VEGF, VEGF receptor 2. EC uptake of Tspan8-CD49d complex-containing exosomes was accompanied by enhanced EC proliferation, migration, sprouting, and maturation of EC progenitors. Unraveling these new pathways of exosome-initiated EC regulation could provide new options for therapeutic interference with tumor-induced angiogenesis.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20124479     DOI: 10.1158/0008-5472.CAN-09-2470

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  236 in total

1.  APC-activated long noncoding RNA inhibits colorectal carcinoma pathogenesis through reduction of exosome production.

Authors:  Feng-Wei Wang; Chen-Hui Cao; Kai Han; Yong-Xiang Zhao; Mu-Yan Cai; Zhi-Cheng Xiang; Jia-Xing Zhang; Jie-Wei Chen; Li-Ping Zhong; Yong Huang; Su-Fang Zhou; Xiao-Han Jin; Xin-Yuan Guan; Rui-Hua Xu; Dan Xie
Journal:  J Clin Invest       Date:  2019-01-14       Impact factor: 14.808

2.  Role of exosomes released by chronic myelogenous leukemia cells in angiogenesis.

Authors:  Simona Taverna; Anna Flugy; Laura Saieva; Elise C Kohn; Alessandra Santoro; Serena Meraviglia; Giacomo De Leo; Riccardo Alessandro
Journal:  Int J Cancer       Date:  2011-08-08       Impact factor: 7.396

Review 3.  Exosomes: immune properties and potential clinical implementations.

Authors:  Nathalie Chaput; Clotilde Théry
Journal:  Semin Immunopathol       Date:  2010-12-21       Impact factor: 9.623

Review 4.  Tetraspanins and tumor progression.

Authors:  Mekel M Richardson; Lisa K Jennings; Xin A Zhang
Journal:  Clin Exp Metastasis       Date:  2010-12-24       Impact factor: 5.150

Review 5.  Pluripotent Stem Cells and Other Innovative Strategies for the Treatment of Ocular Surface Diseases.

Authors:  Johanna Erbani; Daniel Aberdam; Jerome Larghero; Valérie Vanneaux
Journal:  Stem Cell Rev Rep       Date:  2016-04       Impact factor: 5.739

Review 6.  Emerging roles of extracellular vesicles in neurodegenerative disorders.

Authors:  Yang You; Tsuneya Ikezu
Journal:  Neurobiol Dis       Date:  2019-06-20       Impact factor: 5.996

7.  Exosomes derived from Epstein-Barr virus-infected cells are internalized via caveola-dependent endocytosis and promote phenotypic modulation in target cells.

Authors:  Asuka Nanbo; Eri Kawanishi; Ryuji Yoshida; Hironori Yoshiyama
Journal:  J Virol       Date:  2013-07-17       Impact factor: 5.103

8.  Protein targeting to exosomes/microvesicles by plasma membrane anchors.

Authors:  Beiyi Shen; Ning Wu; Jr-Ming Yang; Stephen J Gould
Journal:  J Biol Chem       Date:  2011-02-07       Impact factor: 5.157

9.  Decoding the Role of Extracellular Vesicles in Liver Diseases.

Authors:  Fengyan Deng; Nancy Magee; Yuxia Zhang
Journal:  Liver Res       Date:  2017-12-07

Review 10.  The potential of tumor-derived exosomes for noninvasive cancer monitoring.

Authors:  Theresa L Whiteside
Journal:  Expert Rev Mol Diagn       Date:  2015-08-02       Impact factor: 5.225

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.